资讯

Targeted Oncology14 小时
Identifying Situations Where CTLA-4 Addition Improves NSCLC Outcomes
During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...